precise cause of NGU was unknown, but recent advances in laboratory isolation capability have afforded a clearer understanding of the organisms responsible. Chlamydia trachomatis and Ureaplasma urealyticum are now known to cause approximately 80% of NGU. a The impact of NGU--ranging from months of discomfort to infertility--is of major consequence. In this review of the epidemiotogy, clinical manifestations, diagnostic strategies, and treatment of NGU, attention is focused on urethritis in the male. Information about female infection is included to give a clearer understanding of the transmission and complications of the disease.
EPIDEMIOLOGY
In Great Britain the prevalence of NGU is twice that of gonococcal urethritis (GC). 4 In the United States NGU is not a reportable disease, so accurate national estimates are not available. However, most sexually transmitted disease clinics report that NGU is two to three times more prevalent than GC. s0 6 Chlamydial infections are the most common sexually transmitted diseases in the United States. 7 Estimates place the annual incidence of chlamydial infections in the United States at about three to four million, e Nongonococcal urethritis is most often seen in young adults, particularly blacks and individuals of lower socioeconomic status. Multiple sexual partners, the use of no contraception or a nonbarrier method, and, in men, heterosexuality, also increase the chances of infection. 9' 10 Complicating epidemiologic investigation, NGU is frequently associated with GC. Concomitant chlamydial infection is found in 15 to 30% of men and 25 to 50% of women who have gonorrhea?' n-la As many as a third of men with gonorrhea who receive adequate antibiotic coverage for gonorrhea only will subsequently develop postgonococcal urethritis. 
CLINICAL MANIFESTATIONS
The average incubation period for NGU is two to three weeks. However, correlation of symptom onset with the history of sexual activity of the individual is often difficult. A spectrum of urethral symptoms exists. As many as 25% of men who have positive chlamydial cultures are asymptomatic, although they may have evidence of urethral inflammation. When symptoms do occur, they consist of a urethral discharge, dysuria, or penile discomfort. The discharge is typically scanty and mucoid-white, but may range from clear to purulent. 27 It is often evident only in the morning or after the urethra has been stripped. In general symptoms of NGU are mild and insidious, unlike those of GC. A discharge that is both spontaneous and purulent has a 95% sensitivity for predicting gonorrhea. 28 However, considerable overlap of symptoms exists, so that a diagnosis of NGU cannot be made solely on clinical grounds. 29 Epididymitis occurs as a complication in approximately 2% of men who have NGU. However, C.
trachomatis has been isolated from the urethras of over half of men under age 35 who have acute epididymitis.30. 3~ Positive epididymal aspirates have confirmed the role of chlamydia in producing epididymal infection, although no evidence of Ureaplasma involvement has been found. 32 Other complications of NGU are conjunctivitis, proctitis, and probably Heiter's disease. Adult inclusion conjunctivitis resulting from C. trachomatis usually presents with papillae and follicles forming on the tarsal conjunctiva, associated with a profuse discharge. 33 Diagnosis is made by culture or antigenic detection of chlamydia in conjunctival scrapings. The disease is usually self-limited, but can occasionally become chronic and lead to the corneal changes seen in trachoma. 34 Systemic therapy of both patient and sexual partners is necessary, as conjunctival inoculation invariably results from concomitant genital infection. 35 Chlamydia trachomatis can be found on culture of rectal specimens from asymptomatic carriers, and can cause acute proctitis in homosexual men and in heterosexual women who have histories of anal intercourse. Sigmoidoscopy reveals mild mucosal friabil/ty, erythema, and/or ulceration in the distal 10 cm of the rectum. 3e
Although classic descriptions of Reiter's syndrome consist of the triad of arthritis, conjunctivitis, and urethritis, the working definition of Reiter's disease has now been simplified. Reiter's syndrome is defined as an episode of peripheral arthritis of more than a month's duration occurring in association with urethritis and/or cervicitis, s7 Both chlamydia and Ureaplasma have been causally implicated, although roles for other organisms or environmental triggers are possible. 22" ss, s9 In addition, with the advent of genetic markers and histocompatibility antigen (HLA) system associations, HLA-B27-positive men with NGU have been found to have a 20% risk of developing Reiter's disease. 4° However, no organism has consistently been isolated from affected joint fluids, and the precise mechanism responsible for triggering the inflammatory response remains unclear. 41
In the female, C. trachomatis can cause nongonococcal mucopurulent cervicitis, urethritis, and the acute urethral syndrome. 42 Mucopurulent cervicitis is diagnosed by finding a mucopurulent endocervical discharge [with more than ten polymorphonuclear leukocytes (PMNs) per oil immersion field on Gram stain], coupled with cervical erythema, edema, or friability. Under these circumstances, when the gonococcal culture is negative, the diagnosis of nongonococcal cervicitis is made. 9"4s Chlamydial urethritis in women presents as urinary frequency or dysuria in the setting of sterile pyuria without bacteriuria. ~' 45 Over a third of female contacts of men who develop NGU are symptomatic cervical carriers of chlamydia. 46 This is significant because the asymptomatic carrier could act as a reservoir for the spread of disease. Reported complications of C. trachomatis infection in women are pelvic inflammatory disease, acute perihepatitis, and endometritis. ~' 47, 4s Twenty-five to fifty per cent of all cases of pelvic inflammatory disease are caused by chlamydia, which may increase the risk of infertility and ectopic pregnancy. 4~ No conclusive evidence has been found to implicate chlamydia as a cause of bartholinitis, cervical dysplasia, or maternal infection. In addition, Ureaplasma has not been clearly implicated in gynecologic or maternal infection, z~ Perinatal morbidity is common in newborns whose mothers are carriers of chlamydia. As many as 50% of these newborns develop either conjunctivitis or pneumonitis, s In contrast, Ureaplasma has not been shown to cause perinatal disease, s°
DIAGNOSIS
A variety of other problems can cause urethritis-like symptoms and may be mistaken for NGU. These include local trauma and chemical irritation, urinary tract infection, bladder calculi, and prostatitis. Urethral foreign body, stricture, venereal warts, and ulceration may also mimic NGU. In general, a diagnosis of urethritis is confirmed by a Gram stain of the urethral discharge showing four or more PMNs per oil-immersion field. 2s It may be necessary to strip the urethra from the base of the penis to the meatus to produce an adequate specimen. Stripping the urethra before first voiding in the morning or at least two to three hours after last urination will increase the yield. If no discharge can be produced, a specimen for Gram staining may be obtained by inserting a thin calcium alginate swab approximately 2 cm into the urethra.
Thirty per cent of men who have urethral infections may not meet the above diagnostic criteria for urethritis, s~ When symptoms are highly suggestive of urethritis, even small numbers of PMNs are usually indicative of urethritis. In selected cases where the diagnosis is questionable, examination of firstvoided urine may aid in diagnosis. More than ten PMNs per "high-dry" field (400-power magnification) in a centrifuged specimen of the first 10 ml of urine, followed by a midstream sample containing fewer PMNs, confirms the diagnosis of urethritis.
Once urethral inflammation is detected, gonorrhea must be excluded. Gram stain of the urethral smear is 98% sensitive and specific for GC in symptomatic men when typical kidney-shaped gram-negative diplococci are found within the cytoplasm of PMNs. 28 In equivocal cases where atypical gramnegative diplococci are intracellular or any gramnegative diplococci are extracellular, culture is necessary for diagnosis. 2, 29, s2
The diagnosis of NGU is made after GC is excluded, although this does not identify the responsible organism. Confirmation of chlamydial infection is dependent on culture or antigenic detection methods. However, one may elect to treat these infections empirically. Culture is the reference standard, estimated to be 80 to 95% sensitive and 100% specific. 9 Two methods to detect chlamydia are now commercially available. Although less accurate, they are faster, easier, and slightly less expensive than culture.
MicroTrak ®, produced by Syva Diagnostics, is a direct fluorescent monoclonal antibody staining test that takes about 30 minutes to process. Specimens are smeared on a glass slide. After air drying, the specimen is fixed and stained with monoclonal antibody conjugated with fluorescein isothiocyanate. It is then examined under a fluorescence microscope for chlamydia elementary bodies, which have a characteristic shape and an "apple-green" color. The direct fluorescent antibody stain has greater than 90% sensitivity and 98% specificity. 9, s3, s4 Expertise with immunofluorescence microscopy is necessary for accurate results.
Chlamydiazyme ® is a four-hour enzyme immunoassay produced by Abbott Laboratories. The urethral swab is obtained and placed in a transport storage reagent. In the laboratory, dilution buffer and polyclonal antibody are added. After incubation, the antigen-antibody reaction is measured by an enzyme-linked immunoabsorbent assay and recorded by spectrophotometry. Sensitivity is 90% for detecting cervicitis and 79% for detecting male urethritis; specificity is 97% 9, ss Currently, U. urealyficum can be detected by culture only at specific reference laboratories. The utility of culture is questionable, since the organism may be part of the normal genital flora in healthy sexually active adults, and it is unclear what serotype or quantity of the organism is pathogenic. Further study is necessary before advocating Ureaplasma culture as a routine clinical procedure.
When should the pathogenesis of NGU be pursued? It is not necessary in the management of men who have uncomplicated urethritis, since the diagnosis is readily made and the same first-line antibiotics cover both major organisms. However, in women and children, symptoms and signs may be less specific for chlamydial infection. The most costeffective strategy appears to be empiric therapy for high-risk women, and culture or antigenic detection for confirmation and appropriate treatment in the low-risk group, s6 Also, the potential for serious complications from untreated infection is greater in women. Furthermore, screening for chlamydia may also be useful in managing those who would not be treated on a presumptive basis (such as pregnant women with multiple sexual partners). 9" ,0
TREATMENT
Without treatment, symptomatic NGU can persist for several months, increasing the risk of complications and spread of infection. Tetracycline and erythromycin are effective against both of the agents that cause NGU, while sulfa and high-dose amoxicillin eliminate chlamydiaY' s8 Penicillin, ampicillin and the cephalosporins have limited antichlamydial activity, s9, 80 Currently, the antibiotic of choice for NGU is tetracycline hydrochloride, while doxycycline and erythromycin are effective alternatives (Table 1) . s2' sT, s8 Treatments with tetracyclines have ranged from single doses to 2 l-day therapy, although seven days of treatment appears to provide optimal results. Tetracycline also adequately treats most concomitant uncomplicated urogenital gonorrhea. However, optimal therapy for concomitant NGU and GC includes a single oral dose of amoxicillin (or ampicillin) and probenecid, followed by a week of tetracycline. 6'-63
Tetracycline congeners, such as doxycycline and minocycline, are as effective as tetracycline hydrochloride. Although they may be better tolerated and their less frequent dosing intervals increase patient compliance, they are more expensive. 29 Limited data reveal that erythromycin is as effective as tetracycline for treatment of NGU. 64-66 When taken as directed,tetracycline or erythromycin is very effec- Ureaplasma or eradication of a subset of tetracycline-resistant U. urealyticum. One important disadvantage of erythromycin is that it has limited activity against concomitant gonorrhea. Another potential problem is that erythromycin may produce more gastrointestinal intolerance than tetracycline at dosages currently recommended. However, limited studies using lower doses of erythromycin in pregnant women have shown good results ( Table 1) . These dosages may well cause less gastrointestinal distress than the doses now recommended. 68 ' 69 Patients in whom NGU fails to respond to a course of tetracycline or erythromycin must be questioned regarding compliance and their potential for reinfection from a non-treated sexual partner. Infection with Trichomonas vaginalis or Candida albicans, herpes simplex, or a second infection with gonococcus must be excluded. Prolonged courses of tetracycline for three to six weeks are often recommended for resistant cases, but data to support this approach are incomplete, a Effective treatment for persistent chlamydia-negative Ureaplasma-negative urethritis remains uncertain. T° Protracted syruptoms after an adequate antibiotic trial are an indication for urethroscopy to rule out other urethral disease as a cause of symptoms.
Treatment of both the patient and sexual partners is essential, for two reasons. Overlapping treatment of sexual partners seems to reduce the recurrence rate. ~s Second, there is a high prevalence of asymptomatic carriage of chlamydia among both male and female sexual contacts of infected patients. In untreated women, there is a potential risk of adverse reproductive sequelae and perinatal morbidity.
Control measures to decrease transmission of NGU are not well established. The use of barrier methods of contraception (such as a condom or diaphragm) will reduce the transmission of chlamydia and Ureaplasma. However, it is unclear whether voiding or washing after intercourse, circumcision, or the use of intravaginal spermicides have any effect. ~ In one controlled study,the use of prophylaxis (200 mg of minocycline six to 12 hours after intercourse) markedly reduced the risk of acquiring NGU. 3
